Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 193

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Hereditary breast cancer

Open access
Andrés Conejero, Raquel, Lastra del Prado, Rodrigo, Zurera Berjaga, María, Arévalo Vázquez, Estefanía · 2022 · Revisiones en Cáncer

Abstract

Hasta el 10 % de los pacientes con cáncer de mama (CM) han heredado mutaciones en línea germinal que a menudo conducen a la pérdida de la función de los genes implicados en la reparación del ADN y a la activación del punto de control del ciclo celular.Además de los genes BRCA1 y BRCA2, se ha establecido asociación con riesgo elevado o moderado de cáncer de mama para otros genes, como PALB2, ATM y CHEK2.La incorporación de técnicas de NGS al estudio genético permite su identificación.Los individuos portadores sanos y afectados pueden beneficiarse de recomendaciones de medidas de detección precoz y de reducción de riesgo.Actualmente, las opciones de tratamiento son limitadas para los pacientes con CM mutado en gBRCA.Los inhibidores de la poli(ADP-ribosa) polimerasa (PARP) son una opción terapéutica dirigida que ha demostrado actividad en el cáncer de mama hereditario.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.20960/revcancer.00003

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 193

Metadata

Authors
Andrés Conejero, R., Lastra del Prado, R., Zurera Berjaga, M., & Arévalo Vázquez, E.
Venue
Revisiones en Cáncer
Published
2022
ISSN
0213-8573 (ISSN-L)
OpenAlex
W4317422726
Cited by
193
References
6
FWCI
0.00
Type
journal article
Language
es
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hereditary breast cancer. https://app.cochat.ai/papers/10.20960/revcancer.00003
The paper
Andrés Conejero, R., Lastra del Prado, R., Zurera Berjaga, M., & Arévalo Vázquez, E. (2022). Hereditary breast cancer. Revisiones en Cáncer. https://doi.org/10.20960/revcancer.00003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.